Position in OGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$202,951
+$113,167 QoQ
Shares Held
14,989
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#232
of 626 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CIDEL ASSET MANAGEMENT INC holds $84,525,882 across 11 Drug Manufacturers - General names. OGN ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
234,663 | $44,496,798 | |
| 2 | LLY |
ELI LILLY & Co
|
19,854 | $23,813,485 | |
| 3 | JNJ |
Johnson & Johnson
|
16,136 | $4,098,059 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,925 | $2,431,862 | |
| 5 | PFE |
Pfizer Inc
|
97,941 | $2,358,419 | |
| 6 | ABBV |
AbbVie Inc.
|
9,259 | $2,329,934 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
33,042 | $1,903,880 | |
| 8 | AMGN |
Amgen Inc
|
3,794 | $1,373,883 |
All Filings in OGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202,951 | 14,989 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $89,784 | 14,989 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||